WO2006083950A3 - Method for reducing the level of peroxides in bopcompatible polymer preparations - Google Patents

Method for reducing the level of peroxides in bopcompatible polymer preparations Download PDF

Info

Publication number
WO2006083950A3
WO2006083950A3 PCT/US2006/003524 US2006003524W WO2006083950A3 WO 2006083950 A3 WO2006083950 A3 WO 2006083950A3 US 2006003524 W US2006003524 W US 2006003524W WO 2006083950 A3 WO2006083950 A3 WO 2006083950A3
Authority
WO
WIPO (PCT)
Prior art keywords
peroxides
level
bopcompatible
reducing
polymer preparations
Prior art date
Application number
PCT/US2006/003524
Other languages
French (fr)
Other versions
WO2006083950A2 (en
Inventor
Pamela J Fereira
Michael A Desjardin
Catherine M Rohloff
Stephen A Berry
Ekaterina Zlatkova-Karaslavova
Original Assignee
Alza Corp
Pamela J Fereira
Michael A Desjardin
Catherine M Rohloff
Stephen A Berry
Ekaterina Zlatkova-Karaslavova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/183,477 external-priority patent/US8496943B2/en
Application filed by Alza Corp, Pamela J Fereira, Michael A Desjardin, Catherine M Rohloff, Stephen A Berry, Ekaterina Zlatkova-Karaslavova filed Critical Alza Corp
Publication of WO2006083950A2 publication Critical patent/WO2006083950A2/en
Publication of WO2006083950A3 publication Critical patent/WO2006083950A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

The present invention is related to materials and methods for forming polymeric delivery vehicles that reduces risk of oxidative degradation of a carried drug and the resulting compositions. A method is described to reduce the level of peroxides in biocompatble polymer preparations .
PCT/US2006/003524 2005-02-03 2006-02-01 Method for reducing the level of peroxides in bopcompatible polymer preparations WO2006083950A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US65025205P 2005-02-03 2005-02-03
US60/650,252 2005-02-03
US11/183,477 US8496943B2 (en) 2003-03-31 2005-07-18 Non-aqueous single phase vehicles and formulations utilizing such vehicles
US11/183,477 2005-07-18

Publications (2)

Publication Number Publication Date
WO2006083950A2 WO2006083950A2 (en) 2006-08-10
WO2006083950A3 true WO2006083950A3 (en) 2006-11-23

Family

ID=36694246

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2006/003524 WO2006083950A2 (en) 2005-02-03 2006-02-01 Method for reducing the level of peroxides in bopcompatible polymer preparations
PCT/US2006/003858 WO2006084140A2 (en) 2005-02-03 2006-02-03 Method for reducing the level of peroxides in bopcompatible polymer preparations

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US2006/003858 WO2006084140A2 (en) 2005-02-03 2006-02-03 Method for reducing the level of peroxides in bopcompatible polymer preparations

Country Status (6)

Country Link
EP (1) EP1843747A2 (en)
AR (1) AR054221A1 (en)
AU (1) AU2006210560A1 (en)
CA (1) CA2596860A1 (en)
NO (1) NO20074476L (en)
WO (2) WO2006083950A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
CN103841556A (en) * 2014-03-21 2014-06-04 北京航空航天大学 Method for rapid switching of wireless local area networks
CN115666621A (en) 2020-01-13 2023-01-31 度勒科特公司 Sustained release drug delivery systems with reduced impurities and related methods

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089335A2 (en) * 2003-03-31 2004-10-21 Alza Corporation Non-aqueous single phase vehicles and formulations utilizing such vehicles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089335A2 (en) * 2003-03-31 2004-10-21 Alza Corporation Non-aqueous single phase vehicles and formulations utilizing such vehicles
US20050008661A1 (en) * 2003-03-31 2005-01-13 Fereira Pamela J. Non-aqueous single phase vehicles and formulations utilizing such vehicles
US20050276856A1 (en) * 2003-03-31 2005-12-15 Fereira Pamela J Non-aqueous single phase vehicles and formulations utilizing such vehicles

Also Published As

Publication number Publication date
NO20074476L (en) 2007-11-02
AU2006210560A1 (en) 2006-08-10
EP1843747A2 (en) 2007-10-17
WO2006084140A2 (en) 2006-08-10
WO2006083950A2 (en) 2006-08-10
WO2006084140B1 (en) 2007-03-15
CA2596860A1 (en) 2006-08-10
WO2006084140A3 (en) 2007-01-11
AR054221A1 (en) 2007-06-13

Similar Documents

Publication Publication Date Title
WO2006125082A3 (en) Hydrogels and hydrogel particles
WO2009081169A3 (en) Biodegradable contrast agents
EP1486195A3 (en) Personal product compositions comprising structured benefit agent pre-mix or delivery vehicle and providing enhanced effect of optical modifier separate from structured benefit agent
WO2006107903A3 (en) Polymeric micelles for drug delivery
WO2006052968A3 (en) Stabilized ramipril compositions and methods of making
WO2007076371A3 (en) Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same
WO2005112633A3 (en) Compounds and compositions for delivering active agents
WO2006108009A3 (en) Controlled degradation materials for therapeutic agent delivery
WO2005084637A3 (en) Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof
WO2006047409A3 (en) Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds
WO2006071613A3 (en) Injectable non-aqueous suspension
WO2008034124A3 (en) Targeted polymeric prodrugs containing multifunctional linkers
WO2005089805A3 (en) Polymer-based compositions and conjugates of hiv entry inhibitors
WO2006071693A3 (en) Injectable non-aqueous suspension
WO2007140312A3 (en) Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hydrogel formulations
WO2006083991A3 (en) Fiber-reinforced composite absorbable endoureteral stent
WO2006039704A3 (en) Pharmaceutical composition and method for treating a joint capsule arthropathy
WO2006060815A3 (en) Fibrous structures comprising a nanoparticle additive
WO2007038246A3 (en) Solid polymer delivery compositions and methods for use thereof
WO2007147010A3 (en) Implantable medical devices and methods for making the same
WO2008131451A3 (en) Pva-paa hydrogels
WO2006121522A3 (en) Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions
WO2008010991A3 (en) Methods and compositions for the treatment of cancer
WO2005037323A3 (en) Use of gro to treat or prevent inflammation
WO2010033726A3 (en) Drug delivery composition comprising a self-assembled gelator

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06720059

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 06720059

Country of ref document: EP

Kind code of ref document: A2